Join Mini Med School “deans” Laurel Wysong Rice, MD, and Rebecca Minter, MD, in welcoming our featured speakers. This session's topic is personalized medicine.
Elizabeth Burnside, MD, MPH
Elizabeth Burnside received her MD degree combined with a master’s in public health. Between radiology residency and fellowship she received her master's in biomedical informatics. This foundation underpins her multidisciplinary research program focusing on decision support designed to improve the population based screening and diagnosis of breast cancer.
In July 2017, she was named associate dean of team science and interdisciplinary research for the UW School of Medicine and Public Health and multiple primary investigator of the Institute for Clinical and Translational Research at the University of Wisconsin. In these roles, she strives to create networks and build capacity to translate the remarkable research innovation developed at UW to improve human health in the clinic and in the community. As one of the UW-Madison site primary investigators of the All of Us—Wisconsin initiative, Burnside and the large All of Us team is working provide the foundation for the transition to personalized medicine and precision health.
Dustin Deming, MD
Dustin Deming, MD is a gastrointestinal oncologist at the University of Wisconsin Carbone Cancer Center with a subspecialty focus in the treatment of colorectal and pancreatic cancers. His clinical and basic science research focus on the identification of new treatment strategies for cancer subtypes, including precision medicine and immunotherapies. He is also co-leader of the Carbone Cancer Center Precision Medicine Molecular Tumor Board.
Lee Gravatt Wilke, MD
Lee Gravatt Wilke is the chair of the Division of General Surgery, the director of the University of Wisconsin Health Breast Center in Madison and a professor of surgery. She received her undergraduate and medical degrees from Duke University. From 1993 to 2000, Wilke attended the University of Michigan for her surgical residency. In 2000, Wilke returned to Duke and during her ten years, she assisted in the development of a novel Breast Cancer Survivor and Breast Wellness clinic for high risk patients.
In 2010, Wilke moved to Madison as the director of the UW Health Breast Center and established a five-year strategic plan to rapidly expand the research and clinical programs. Wilke is currently the chair of the research committee for the American Society of Breast Surgeons as well as member of the board of directors for the Alliance for Clinical Trials. She is the principal investigator for the UW National Clinical Trials Network LAPs grant and works locally and nationally to provide innovative device and pharmaceutical clinical trials for cancer patients. In addition to caring for breast cancer patients, Wilke enjoys spending time with her husband, Nathan and two sons.
Dhanansayan (Dhanu) Shanmuganayagam, PhD
Dhanansayan (Dhanu) Shanmuganayagam is the director of the Biomedical and Genomic Research Group and the UW Neurofibromatosis Translational Research Program, and an assistant professor (physiology, immunology and nutrition) in the Department of Animal Sciences.
The overarching mission of his research program is to take scientific discoveries and technologies from the bench-top to the human clinical setting in an efficient and rapid manner. He is an expert in creating and utilizing pig models of human disease to achieve this mission. He currently leads the genetic engineering of pigs at UW–Madison to more precisely model human patients and provide platforms for personalized medicine research.
Richard Moss, PhD
Richard Moss is senior associate dean for basic research, biotechnology and graduate studies in the University of Wisconsin School of Medicine and Public Health. Moss served as chair of department from 1988 to 2009. During this time the department grew from 10 to 23 faculty and became one of the leading research departments in the nation. Moss founded the UW Cardiovascular Research Center and the MS in biotechnology degree program.
Moss was an established investigator of the American Heart Association and a recipient of an NHLBI Merit Award. In 2007, he received an honorary doctor of medicine degree from Uppsala University.
Moss’s research focuses on heart failure, its causes, and therapeutic approaches to the disease. His research group is renowned for innovation in approaches to research and in developing new understanding of the basis for health and disease in the heart. He has authored over 180 papers and has supervised more than 20 graduate students and post-doctoral fellows who now hold positions in U.S. academic medical centers.
M. Stephen Meyn, MD, PhD
Stephen Meyn was educated at Princeton University and received his MD degree and PhD from New York University. Trained in pediatrics and medical genetics, he held faculty positions at Yale University and the University of Toronto prior to being recruited to UW-Madison last year to direct the School of Medicine and Public Health's Center for Human Genomics and Precision Medicine.
Meyn’s work encompasses the full range of genomics research – from fundamental studies of genome stability to evaluations of the clinical applications of whole genome sequencing and the ethics of predictive genomic testing. While in Toronto, Meyn co-led the Hospital for Sick Children’s Genome Clinic Project, which was the first to pioneer the use of comprehensive diagnostic and predictive whole genome sequencing in children. His current research focuses on two of the major challenges in genomic medicine: discovering new disease genes and developing high-throughput methods for rapidly identifying pathogenic genomic variants.